2013
DOI: 10.1111/neup.12032
|View full text |Cite
|
Sign up to set email alerts
|

Abnormal RNA structures (RNA foci) containing a penta‐nucleotide repeat (UGGAA)n in the Purkinje cell nucleus is associated with spinocerebellar ataxia type 31 pathogenesis

Abstract: Spinocerebellar ataxia type 31 (SCA31) is an autosomal-dominant cerebellar ataxia showing a Purkinje cell (PC)-predominant neurodegeneration in humans. The mutation is a complex penta-nucleotide repeat containing (TGGAA)n , (TAGAA)n , (TAAAA)n and (TAGAATAAAA)n inserted in an intron shared by two different genes BEAN1 and TK2 located in the long arm of the human chromosome 16. Previous studies have shown that (TGGAA)n is the critical component of SCA31 pathogenesis while the three other repeats, also present i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
47
1

Year Published

2013
2013
2023
2023

Publication Types

Select...
7
3

Relationship

2
8

Authors

Journals

citations
Cited by 51 publications
(49 citation statements)
references
References 23 publications
1
47
1
Order By: Relevance
“…Recent advances in whole genome sequencing have revealed significant complexity in the molecular ''lesions'' underlining human diseases and many of the gene products associated with these lesions are considered ''undruggable'' with traditional therapeutic approaches (Wheeler et al, 2012;NiiMi et al, 2013). Oligonucleotide-based antisense technology is theoretically ideal for treatment of these otherwise ''undruggable'' targets.…”
Section: Discussionmentioning
confidence: 99%
“…Recent advances in whole genome sequencing have revealed significant complexity in the molecular ''lesions'' underlining human diseases and many of the gene products associated with these lesions are considered ''undruggable'' with traditional therapeutic approaches (Wheeler et al, 2012;NiiMi et al, 2013). Oligonucleotide-based antisense technology is theoretically ideal for treatment of these otherwise ''undruggable'' targets.…”
Section: Discussionmentioning
confidence: 99%
“…These findings may suggest that SCA36 pathological features are distinct from those of non-coding repeat expansion disorders. Future investigations should search for abnormal RNA structures (‘RNA foci’) in these affected neuronal cells, as have been detected in other related diseases caused by repeat expansions in introns: myotonic dystrophy type 2 (DM2),7 SCA1020 and SCA31 8 21…”
Section: Discussionmentioning
confidence: 99%
“…The impairments that we observed in the abrupt protocol reproduced results of a number of previous prism adaptation studies (Martin et al 1996;Milder and Reinecke 1983;Weiner et al 1983). Although lesions in these previous studies were not necessarily restricted to the cerebellum, all patients studied here had pure cerebellar type deficits with little involvement of other systems: SCA6 is characterized mainly by degeneration of Purkinje cell in the superior parts of the vermis and hemispheres (Ishikawa et al 1999;Sasaki et al 1998;Takahashi et al 1998), and SCA31 also results mainly in degeneration of Purkinje cells (Niimi et al 2013;Seidel et al 2012), although regions other than the cerebellar cortex may also be affected in SCA6 or SCA31 (Seidel et al 2012;Wang et al 2010). The present results expand previous findings by suggesting that Purkinje cell dysfunction leads to impairments in prism adaptation in humans.…”
Section: Discussionmentioning
confidence: 99%